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Abstract: Biomaterial-based blood clot formation is one of the biggest drawbacks of blood-contacting
devices. To avoid blood clot formation, their surface must be tailored to increase hemocompatibility.
Most synthetic polymeric biomaterials are inert and lack bonding sites for chemical agents to bond
or tailor to the surface. In this study, polyethylene terephthalate was subjected to direct current
air plasma treatment to enhance its surface energy and to bring oxidative functional binding sites.
Marine-sourced anticoagulant sulphated polysaccharide fucoidan from Fucus vesiculosus was then
immobilized onto the treated polyethylene terephthalate (PET) surface at different pH values to
optimize chemical bonding behavior and therefore anticoagulant performance. Surface properties
of samples were monitored using the water contact angle; chemical analyses were performed by
FTIR and X-ray photoelectron spectroscopy (XPS) and their anticoagulant activity was tested by
means of prothrombin time, activated partial thromboplastin time and thrombin time. On each of the
fucoidan-immobilized surfaces, anticoagulation activity was performed by extending the thrombin
time threshold and their pH 5 counterpart performed the best result compared to others.
Keywords: polyethylene terephthalate; fucoidan; blood coagulation; anticoagulant; plasma treatment;
surface coating
1. Introduction
Besides adequate mechanical performances of polymeric biomaterials, their surface properties
(surface chemistry, hydrophilicity, energy and charge density) and their interactions with living
tissue are equally essential to ensure biocompatibility. In the case of blood-contacting medical
devices, such as vascular graft and stents, heart valves and intravascular catheters, regulating the
blood–material interface is required to regulate hemocompatibility. The major drawback of such
biomaterials (i.e., polyethylene terephthalate, polylactic acid, polycaprolactone and their nanofibers)
is their insufficient hemocompatibility, which triggers thrombus formation on the material surface
(namely, surface-induced thrombus formation) and may cause failure of the implanted material,
vascular occlusion, heart attack and stroke [1–7].
The first response of the body to the implanted biomaterial is rapid protein adsorption within
seconds, in accordance with the Vroman Effect, which leads to platelet adhesion and mediates thrombus
formation [8–12]. This protein layer is recognizable by the integrin receptors of the cells; hence, protein
adsorption is important for cellular interactions as well [13–17].
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Platelet adhesion onto the protein layer is followed by platelet aggregation and activation of the
intrinsic pathway of the blood coagulation cascade by blood protein factor XII (also called coagulation
factor) to XIIa, fibrin network formation and finally complement system activation via erythrocytes and
leukocytes interactions [18–21]. This activated blood coagulation cascade triggers thrombus formation
on the biomaterial’s surface (surface-mediated thrombosis) [22].
Hence, reducing the protein adhesion at the beginning onto the biomaterial’s surface is the
key point to prevent platelet adhesion, and therefore thrombus formation, for short- and long-term
hemocompatibility of blood-contacting devices.
Modification of the biomaterial’s surface can be considered for two approaches: first, tailoring
the physical properties to change its surface topography, and therefore hydrophilicity and cellular
interactions; second, chemical immobilization of a bioactive agent to obtain specific features according
to the individual properties of the chemical agent. Immobilization of a bioactive agent onto a polymeric
substrate is challenging due to the hydrophobic nature and lack of the bonding interfaces to create a
covalent bond with the chemical agents for most of the polymeric materials. There are several methods
to treat polymeric surfaces, such as wet chemistry, UV irradiation, corona discharge, flame treatment,
ozone-induced treatment and plasma treatment [23–28]. Besides efficiency of the immobilization,
desired bulk properties are equally important, especially for heat-sensitive and chemically unstable
substrates. Therefore, plasma treatment is one of the best candidates for etching the surface to change its
topography (therefore increasing its hydrophilicity and surface area) homogeneously and to introduce
the beneficial functional hydroxyl, carboxyl and carbonyl groups on the surface for further chemical
bonding with selected chemical agents. Due to the fact that plasma treatment is heat-free and its effect
is limited to the top surface, the bulk properties remain unchanged.
Heparin is a well-known anticoagulant polysaccharide for avoiding blood thrombus, but its
biggest drawbacks are hemorrhage and thrombocytopenia. Furthermore, it may cause animal-based
infections since it is mostly obtained from animals [29–33].
Fucoidan (Figure 1) is a marine-sourced sulphated polysaccharide, extracted from brown algae,
with a better anticoagulant effect than that of anticoagulant heparin due to its action mechanism on the
coagulation cascade by interacting with the natural thrombin inhibitors of antithrombin (AT III), heparin
cofactor II (HCII), activated factor II (thrombin) and activated factor X [30–38]. Fucoidan has numerous
biological activities besides its anticoagulant activity, such as anticancer, antitumor, antivirus and
antiinflammation activities [39–44]. Its effect is related to monosaccharide composition, sulfation degree
and pattern and molecular weight to regulate binding properties [32–34,44,45]. Furthermore, fucoidan
does not cause hemorrhage as heparin does, and it has no risk of inflammation as animal-sourced
heparin does, due to its marine origin [30–32].
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Vesel et. al. studied the fucoidan from Fucus vesiculosus immobilization onto a polyethylene
terephthalate (PET) surface after radio frequency (RF) plasma treatment at different pH values and
demonstrated the immobilization performance by X-ray photoelectron spectroscopy. They found that
the hig st immobilization level occurred at pH 5, but anticoagulation activity was not carried out [46].
In our previous study, fucoidan from Fucus vesiculosus was immobilized onto low density
polyethylene at its natural pH value and it exhibited an antic agulant activity slightly higher than the
threshold [47]. In this study, polyethylene terephthalate (PET) was used as a substrate, due to its unique
chemical and physical properties with highly crystalline structure, to create a functional anticoagulant
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surface using fucoidan from Fucus vesiculosus (FU). PET surfaces were activated by direct current (DC)
plasma to form functional groups for FU immobilizations with pH levels of 3, 4, 5, 6 and 7 to compare
its anticoagulation activity at various pH values, as it depicted in Figure 2. Surface characterizations
were studied by wettability test, scanning electron microscopy, X-ray photoelectron spectroscopy and
Fourier transform infrared spectroscopy. The anticoagulation activity of the samples was carried out for
prothrombin time (PT), activated partial thromboplastin time (aPTT) and thrombin time (TT).
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2. Materials and Methods
2.1. Materials and Preparation of Anticoagulant Surfaces
In this work, polyethylene terephthalate (PET) sheets with 70 × 30 × 0.1 mm dimensions were
used as a polymeric substrate. All PET substrates were thoroughly cleaned with distilled water and
dried at 30 ◦C for 24 h in an ove . PET sub trates were ex to dire t current (DC) plasma at 50 W
of reactor p wer and 40 kHz of frequency, gen rated b PICO (Diener, Germany) pl sma reactor
under the chamber pressure of 50 Pa. As a discharge gas, air was used with 20 sccm flow rate, and
both sides of PET sheets were treated for 60 s, hereafter referred to as PET_DC. Anticoagulant fucoidan
from Fucus vesiculosus (FU) (Sigma Aldrich, St. Louis, MO, USA) solution was prepared as 1% (w/v) in
distilled water and pl ced in the vials to change their pH. The total v lume of the FU solutions in vials
was 4 mL each. The pH values of the FU solutions of pH = 3, 4, 5, 6 and 7 were obtained by diluted
H2SO4 addition. PET_DC samples were subsequently placed into each solution vial containing FU
solution with pH = 3, 4, 5, 6 and 7 and placed in a rotational shaker for 24 hours at room temperature in
order to im obiliz anticoagulant fucoida onto t e f nctionalized surface of PET by plasma. Samples
were labeled as FU3, FU4, FU5, FU6 and FU7, respectively. Finally, the samples w re taken out of the
solution vials, thoroughly washed with distilled water to eliminate non-immobilized fucoidan species
and dried at room temperature for 24 h. Each sample was placed into a separated blood collection tube
for further anticoagulation activity evaluation.
2.2. Surface Wettability Evaluation
The wettability behavior of the samples to determine its surface hydrophilicity was studied by the
Sessile drop method via SEE System (Advex Instruments, Brno, Czech Republic) equipped with a CCD
camera. Distilled water was used as the testing liquid at 22 ◦C and 60% relative humidity. Ten separate
droplets with a volume of 5 µL were placed onto each sample surface for 30 s to obtain the average
water contact angle value (Qw).
2.3. Surface Morphology Investigation by SEM
Surface morphology of all samples was monitored by a NANOSEM 450 (FEI, Hillsboro, OR, USA)
scanning electron microscope (SEM), equipped with a low vacuum detector and operated at 5 kV
under 90 Pa pressure in a water vapor environment. Images were taken at the magnification of 10 k ×
with a spot size of 50 nm.
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2.4. Attenuated Total Reflectance Fourier Transform Infrared Spectroscopy (ATR-FTIR) Analysis
For surface chemistry examination, in order to compare the changes in chemical compositions of
the studied samples, a Nicolet iS5 (Thermo Scientific, Grand Island, NY, USA) single beam Fourier
transform infrared spectroscopy (FTIR) equipped with iD5 attenuated total reflectance (ATR) was used.
Collected spectra were recorded between 400 and 4000 cm−1 with a resolution of 2 cm−1 and 64 scans
using a ZnSe crystal at an incident angle of 45◦.
2.5. X-Ray Photoelectron Spectroscopy (XPS) Analysis
To reveal the changes in chemical composition on the surfaces of the samples, X-ray photoelectron
spectroscopy (XPS) analysis was carried out on a bioemulsifier film deposited on a glass slide using
ESCALAB 200A, VG Scientific (East Grinstead, UK), with PISCES software for data acquisition and
analysis. An achromatic Al (Ka) X-ray source was operated at 15 kV (300 W), and the spectrometer
was calibrated with reference to Ag 3d5/2 (368.27 eV) and operated in constant analyzer energy (CAE)
mode with 20 eV pass energy. Data acquisition was performed with a pressure lower than 10−6 Pa.
Gaussian–Lorentzian peak shape and Shirley type background subtraction were used for peak fitting
of the spectral analysis.
2.6. Evaluation of Anticoagulation Activity
The blood was obtained by venous puncture from a healthy donor in accordance with the Helsinki
Declaration, and placed into blood collection tubes (5 mL each) covered by prepared PET samples. The
obtained human blood plasma was treated with 3.2% citric acid (109 mmol/L) and then centrifuged
at room temperature, 3000 min−1, for 15 min. Anticoagulant activity was determined by means of
prothrombin time (PT), thrombin time (TT) and activated partial thromboplastin time (aPTT) using
a SYSMEX CA 1500 (Siemens, Munich, Germany) instrument. Each of the samples was examined
three times.
3. Results
3.1. Surface Wettability Behavior
Surface wettability results of studied samples, obtained by water contact angle, are given in Table 1.
The water contact angle of 70.6◦ was monitored for the initial PET sample. This value of the water
contact angle is referred to as a hydrophobic nature of the PET surface, which is not convenient for
anticoagulant agent immobilizations. After DC plasma treatment (PET_DC), the water contact angle
value sharply decreased to 22.09◦, due to the introduced functional groups and the increased surface
area by plasma, referring to the increased hydrophilicity and surface energy, which is convenient for
further anticoagulant agent immobilizations. As can be seen in Table 1, FU-immobilized samples at
various pH (samples of FU3 for pH 3; FU4 for pH 4; FU5 for pH 5; FU6 for pH 6 and FU7 for pH 7)
showed almost the same water contact angle values within a range of 39.08◦ to 43.21◦. Such an increase,
compared to the plasma-treated sample, indicates the immobilization of FU onto PET_DC counterparts,
as was demonstrated by SEM analysis.
Table 1. Water contact angle values of the samples.
Samples Contact Angle (◦)
PET 70.6 ± 0.60
PET_DC 22.09 ± 1.32
FU3 43.21 ± 2.67
FU4 39.08 ± 1.74
FU5 42.61 ± 2.92
FU6 39.74 ± 5.52
FU7 42.54 ± 7.45
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3.2. Surface Morphology
The immobilization of fucoidan onto functionalized PET surface was investigated by scanning
electron microscope, and the results are shown in Figure 3. As it is seen in Figure 3a, the reference
PET surface is smooth without impurities; however, after DC plasma treatment it becomes relatively
rough due to the increased surface area by plasma treatment (Figure 3b). The immobilization of
fucoidan species on each sample was monitored, which revealed successful bonding to functional
groups created by plasma. Nevertheless, the particle size and distribution of immobilized fucoidan
species were different for each sample, due to the dissolution ability of fucoidan at different pH values.
According to the SEM results, solubility and immobilization affinity of fucoidan seemed to be the
best at pH 5 (Figure 3e) and pH 4 (Figure 3d). For both FU5 and FU4 samples, the particle size was
smaller (this reduces the fraction of floating blood to decrease the chance of clustering blood particles
such as fibrin and red blood cells, which trigger blood clot formation), and the distribution was more
homogenous than that of the FU3 (Figure 3c), FU6 (Figure 3f) and FU7 (Figure 3g) counterparts. This
was also confirmed by XPS results, showing that sulphur content was much higher for FU5 and FU4
compared to others. Furthermore, as expected, their anticoagulation activity was better, which is
discussed later on.
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3.3. Surface Chemical Anaylsis by ATR-FTIR
The chemical changes in the near-surface area of the samples were observed by attenuated total
reflectance Fourier transform infrared spectra (ATR-FTIR) for the mid-IR range of 4000–400 cm−1, and
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the collected data are shown in Figure 4. The major peaks of PET were observed at the wavenumbers
of: 720 cm−1 related to CH2 rocking vibrations; 795 cm−1 in the plane vibration of C–H; 850 cm−1 and
872 cm-1 corresponding to wagging vibration of O–CH2 and out-of-plane C–H vibration, respectively;
975 cm−1 due to stretching of O–CH2; 1015 cm−1 related to in-plane C–H vibration; 1095 cm−1
and 1243 cm−1 corresponding to asymmetric stretching vibration of C–O; 1340 cm−1 referring to
CH2 wagging; 1410 cm−1 related to C–H bending vibration; 1471cm−1 related to CH2 bending;
1511 cm−1 referring to C–H bending vibration; 1718 cm−1 due to C=O stretching band [48–50]. The
absorption peaks observed between 2850 and 3000 cm−1 were attributed to aliphatic C–H stretching
vibrations [47,50].
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ue to the penetration depth of ATR crystals of ZnSe (0.6 µm), which was well above the thickness
of the coated FU (assumed to be nanometer size), the collected data were mostly belongs to the PET
itself. Nevertheless, between wavenumbers 3000 and 2850 cm−1, especially for the FU5 samples,
a slight intensity increase of peaks was observed, which refers to the immobilization of FU. The peak
corresponds to the OH group vibration from the monosaccharide monomer. The peak at pH 5 showed
the highest obtained intensity due to the highest amount of immobilized FU, as is discussed later on.
3.4. Surface Elemental Analysis by XPS
Surface chemical compositions of the samples were revealed by using X-ray photoelectron
spectroscopy (XPS), and results are listed in Table 2. The XPS spectra of the reference PET sample
consisted only of carbon and oxygen content with the levels of 69.7% and 30.3%, respectively. After
DC plasma treatment, the oxygen level increased to 40.9% due to the oxidative group functionalities
introduced by plasma, and the carbon level decreased proportionally. Likewise, nitrogen was detected
after plasma treatment with a level of 0.7%, due to the amine groups introduced by the applied plasma.
Oxygen and nitrogen levels decreased for all fucoidan-immobilized samples as an indicator of fucoidan
bonding. Nevertheless, sulphur content was lowest for the FU3 sample and highest for the FU5 sample,
which signifies fucoidan immobilization. The highest sulphur content was observed at pH 5. Therefore,
maximum anticoagulation activity is expected for the FU5 counterpart, according to the XPS data.
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Table 2. Collected elemental compositions in atomic percentages of the samples by X-ray photoelectron
spectroscopy (XPS).
Samples C1s O1s N1s S2p O1s/C1s N1s/C1s S2p/C1s
PET 69.7 30.3 0 0 0.435 0 0
PET_DC 58.4 40.9 0.7 0 0.700 0.012 0
FU3 63.4 35.7 0 0.2 0.563 0 0.003
FU4 63.7 34.5 0.2 1.6 0.542 0.003 0.025
FU5 63.6 34.4 0.2 1.8 0.541 0.003 0.028
FU6 63.7 35.7 0.1 0.5 0.560 0.002 0.008
FU7 63.8 35.6 0.1 0.5 0.558 0.002 0.008
3.5. Blood Coagulation Activity
The anticoagulation activity of the samples was examined to reveal prothrombin time (PT),
activated partial thromboplastin time (aPTT) and thrombin time (TT). Therefore, three pathways of the
blood coagulation cascade of the surface-mediated intrinsic pathway, the tissue-mediated extrinsic
pathway and the common coagulation pathway were investigated in vitro and the results are given in
Table 3.
Table 3. Anticoagulation activity results; PT: prothrombin time (s); aPTT: activated partial
thromboplastin time (s); TT: thrombin time (s).
Samples PT aPTT TT
PET 12.6 26.3 15.5
PET_DC 10.9 22 15.2
FU3 11.3 29.4 34.7
FU4 11 35.1 88.7
FU5 10.9 35.1 100+
FU6 11.1 30.8 58.6
FU7 11.2 31.5 60.7
PT measures the clot formation time in the extrinsic pathway, and the common coagulation
pathway and PT range for the healthy donors is between 11 and 13.5 s [51]. According to the results of
the PT assay, all samples are in the range with minor alteration (Figure 5a).
aPTT measures the coagulation activity of the intrinsic pathway and the common coagulation
pathway, in contrast to PT. For the healthy donors, the time range of aPTT is between 25 and 32 s [52].
aPTT assay revealed that the PET surface is in the range by 26.3 s, but after DC plasma treatment
it slightly decreased below the threshold by 22 s (Figure 5b). This is probably due to the increased
surface roughness (which increases the hydrophilicity) that increases the fraction between the material
surface and floating blood. The nitrogen content of PET_DC also needs to be taken into consideration.
Fucoidan-immobilized samples FU3, FU6 and FU7 were within this range. By means of FU4 and FU5
samples, both were above the range by 35.1 s, which retarded the coagulation even further than that of
upper anticoagulant limit of 32 s.
TT measures the thrombin formation time by means of the conversion rate of fibrinogen to fibrin
in the common coagulation pathway. The threshold for the anticoagulation activity is 20 s, which
means a TT over 20 s is considered to be anticoagulant (Figure 5c) [52–54].
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4. Conclusions
In order to achieve anticoagulant activity, a polyethylene terephthalate (PET) surface, for use in
blood-contacting devices, was treated by DC air plasma and fucoidan from Fucus vesiculosus (FU) and
was immobilized in different pH values with a range of 3–7. The FU immobilization onto the PET
surface after plasma treatment was found to be best at pH 5, which it also correlated with FTIR, SEM
and XPS results, and it exhibited the highest anticoagulant activity, more than 100 s, which indicates
that it is a fully anticoagulant FU-immobilized sample suitable for blood-contacting PET devices.
Nevertheless, FU immobilizations were successful for all samples and exhibited anticoagulant activity
well above that of the TT threshold of 20 s.
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